BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16043894)

  • 1. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
    Yamada K; Brink I; Bissé E; Epting T; Engelhardt R
    J Dermatol; 2005 May; 32(5):316-34. PubMed ID: 16043894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) accumulation in melanoma cells: is FDG a substrate of multidrug resistance (MDR)?
    Yamada K; Brink I; Engelhardt R
    J Dermatol; 2005 May; 32(5):335-45. PubMed ID: 16043895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
    Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
    Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
    Park SG; Lee JH; Lee WA; Han KM
    Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
    Paudyal B; Oriuchi N; Paudyal P; Higuchi T; Nakajima T; Endo K
    Cancer Sci; 2008 Feb; 99(2):260-6. PubMed ID: 18271924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
    Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
    Shim HK; Lee WW; Park SY; Kim H; Kim SE
    Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
    Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
    Tohma T; Okazumi S; Makino H; Cho A; Mochiduki R; Shuto K; Kudo H; Matsubara K; Gunji H; Ochiai T
    Hepatogastroenterology; 2005; 52(62):486-90. PubMed ID: 15816463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
    Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
    Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
    J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
    Mamede M; Higashi T; Kitaichi M; Ishizu K; Ishimori T; Nakamoto Y; Yanagihara K; Li M; Tanaka F; Wada H; Manabe T; Saga T
    Neoplasia; 2005 Apr; 7(4):369-79. PubMed ID: 15967114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
    J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose transporter protein-independent tumor cell accumulation of fluorine-18-AFDG, a lipophilic fluorine-18-FDG analog.
    Waki A; Fujibayashi Y; Magata Y; Yokoyama A; Sadato N; Tsuchida T; Ishii Y; Yonekura Y
    J Nucl Med; 1998 Feb; 39(2):245-50. PubMed ID: 9476929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
    Tong SY; Lee JM; Ki KD; Choi YJ; Seol HJ; Lee SK; Huh CY; Kim GY; Lim SJ
    Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
    Minosako Y; Nemoto M; Ino S; Shirakami Y; Kurami M
    Kaku Igaku; 2003 Feb; 40(1):23-30. PubMed ID: 12701204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
    Chung JK; Lee YJ; Kim C; Choi SR; Kim M; Lee K; Jeong JM; Lee DS; Jang JJ; Lee MC
    J Nucl Med; 1999 Feb; 40(2):339-46. PubMed ID: 10025844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
    Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.